Avid Bioservices Inc (CDMO)

[Protector]

Tampa, EVERY of the PR's and Presentations on which I base my conclusions are as real as they get. The only way for them to be what you want to make this is that PPHM would have falsified the data.

But if that is what you claim then I have the benefit of the doubt until you prove the PRs and Presentations of results are fakes.

The results yielded by Bavituximab leave no space for interpretation. They OUTPERFOR the way their control arm durg perform today in the clinic on a day-by-day, year-by-year basis, big time and hands down.

Thet fact that it floats the boat of some not to be willing to compare with the day-to-day data of what Docetaxel does in the field and has been historically established is not my problem.

For me as an investor I need to know if Bavi works, that is, if it performs better then the care available in a meaningful way. The fact that others want to compare it only to in-trail control arms of which it has been disclosed that one was the subject of dose switching in the DISADVANTAGE of Bavituximab (yet Bavi still outperformed it by 60%) and the other abnormally outperformed its own day-to-day/year-to-year and historical trial statistics, doesn't change that.

The only change that that makes it that one cannot file for approval with that data. The Bavituximab results however remain what they are and can be compared to the day-to-day Docetaxel performance to see if it does better and hence is worth investing in. And it does.

So no, Bavituximab works is not an opinion. It is a PROVEN FACT just not with a data set that may be used for filing.